Current Studies
As part of our commitment to be a leader in women’s health care, we continually conduct clinical research studies to advance treatment methods and to identify the most effective means to care for patients. We want to be on the cutting edge of medicine and contribute, first-hand, to benefit not only Rosemark patients but also patients around the world.
Rosemark Clinical Research is now enrolling participants in investigational drug studies in the following areas:
Infant Pneumococcal Vaccine
This is a vaccine study comparing two infant pneumococcal vaccines, one with 5 additional strains of pneumonia.
Overactive Bladder Study
This is a study for both male and female participants with overactive bladder or urge incontinence using the Altaviva device for treatment.
Oral Contraceptive Database
This is a study for Rosemark patients who are starting a new oral contraceptive. Participants fill out a questionnaire every six months for two years.
Fembloc (Femasys)
This study examines the safety and efficacy of an investigational study product for tubal ligation.
